Convergence Investment Partners, LLC Abbott Laboratories Transaction History

Convergence Investment Partners, LLC

$261 Million
Q1 2024

A detailed history of Convergence Investment Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 3,094 shares of ABT stock, worth $322,456. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,094

Previous 3,079 0.49%

Holding current value

$322,456

Previous $339,000 3.83%

% of portfolio

0.13%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $1,642 - $1,814	15 Added 0.49%	3,094 $352,000
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $1,984 - $2,428	-22 Reduced 0.71%	3,079 $339,000
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $3,439 - $4,126	36 Added 1.17%	3,101 $300,000
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $10,783 - $12,015	-107 Reduced 3.37%	3,065 $334,000
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $2,905 - $3,420	-30 Reduced 0.94%	3,172 $321,000

Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $11,692 - $13,716	-123 Reduced 3.7%	3,202 $351,000
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $10,643 - $12,323	-110 Reduced 3.2%	3,325 $322,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $9,594 - $11,596	-94 Reduced 2.66%	3,435 $373,000
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $203,525 - $248,186	-1,785 Reduced 33.59%	3,529 $418,000
Q4 2021 Jan 25, 2022	BUY	$115.53 - $141.46 $185,772 - $227,467	1,608 Added 43.39%	5,314 $748,000
Q3 2021 Oct 25, 2021	BUY	$116.66 - $129.06 $4,433 - $4,904	38 Added 1.04%	3,706 $438,000
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $36,920 - $43,460	-349 Reduced 8.69%	3,668 $425,000
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $8,489 - $10,001	-78 Reduced 1.9%	4,017 $481,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $9,660 - $10,526	92 Added 2.3%	4,095 $448,000
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $9,622 - $11,685	-105 Reduced 2.56%	4,003 $436,000
Q2 2020 Jul 30, 2020	BUY	$76.57 - $98.0 $17,457 - $22,344	228 Added 5.88%	4,108 $376,000
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $13,506 - $19,749	-215 Reduced 5.25%	3,880 $306,000
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $3,532 - $3,933	-45 Reduced 1.09%	4,095 $356,000
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $572 - $621	-7 Reduced 0.17%	4,140 $346,000
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $10,421 - $12,155	143 Added 3.57%	4,147 $349,000
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $2,450 - $2,962	37 Added 0.93%	4,004 $320,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $29,370 - $33,272	448 Added 12.73%	3,967 $287,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $13,256 - $15,992	218 Added 6.6%	3,519 $258,000
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $3,051 - $3,367	53 Added 1.63%	3,301 $201,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $182,764 - $206,637	3,248 New	3,248 $195,000

Others Institutions Holding ABT

# of Institutions

3,133

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.69M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $183B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Account

Convergence Investment Partners, LLC Abbott Laboratories Transaction History